There is strong evidence linking circulating TMAO levels to increased risk for myocardial infarction and stroke[3, 4], even in low risk individuals (e.g., age <65 years, women, low lipid levels, low C-reactive protein (CRP) levels)[5]. Here, CRP is linked to myocardial infarction.